ctrl K

Price Alert

Acurx Pharmaceuticals Inc... (ACXP)

NASDAQ: ACXP · Real-Time Price · USD

5.11

0.25 (5.14%)

At close: Aug 15, 2025, 3:59 PM

5.12

0.20%

After-hours: Aug 15, 2025, 05:58 PM EDT

Acurx Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.71M	7.47M	9.11M	12.96M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	51.13K	129.16K	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	-250	65.00	45.00	-304
Total Current Assets	3.86M	7.71M	9.38M	13.25M
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a
Total Assets	3.86M	7.71M	9.38M	13.25M
Account Payables	n/a	3.81K	29.54K	63.37K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	538.21K	716.19K	543.46K	n/a
Total Current Liabilities	3.24M	3.04M	2.06M	843.91K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	2.06M	n/a
Total Liabilities	3.24M	3.04M	2.06M	843.91K
Total Debt	n/a	n/a	n/a	n/a
Common Stock	17.03K	14.47K	11.63K	10.22K
Retained Earnings	-67.32M	-53.22M	-38.64M	-26.55M
Comprehensive Income	n/a	n/a	-38.64M	-26.55M
Shareholders Equity	615.12K	4.67M	7.32M	12.41M
Total Investments	n/a	n/a	n/a	n/a